TLT8
TLT8 is a ByeTAC protein degrader that targets BTK. It induces BTK degradation by non-covalently binding to Rpn-13 and BTK. TLT8 is applicable in research on chronic lymphocytic leukemia.
Product Specifications
Field of Research
Cardiovascular Research, Pharmacology & Drug Discovery, Signal Transduction
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2074044-01 0.1 mL
FITC-Linked Polyclonal Antibody to Lipocalin 8 (LCN8)
Sign In for Pricing
View Details MBS2074044-02 0.2 mL
FITC-Linked Polyclonal Antibody to Lipocalin 8 (LCN8)
Sign In for Pricing
View Details MBS2074044-03 0.5 mL
FITC-Linked Polyclonal Antibody to Lipocalin 8 (LCN8)
Sign In for Pricing
View Details MBS2074044-04 1 mL
FITC-Linked Polyclonal Antibody to Lipocalin 8 (LCN8)
Sign In for Pricing
View Details